BeStock  
Stocks › Biotechnology › SLN

Silence Therapeutics SLN

US equityMarket cap rank #3022Biotechnology
$19.81 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.81 0.00%
Open$19.81
Prev close$19.81
Day range$19.80 – $19.83
Volume399.1K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership54.9%+5.06 pts vs. prior quarter
Institutions holding94+3 vs. prior quarter
Insider trades (recent)36 buys / 2 sellsNet buying
Short interest3.89% of floatDays to cover 1.0 · as of 30 Oct 2026
Short-sale volume share10.8%5-day average of daily volume

Short-sale volume as % of daily volume

1%8%14%20%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$105.43M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$87.8MSuper−$17.6MBig−$16.3MMid−$7.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 31.4% of shares outstanding.

Largest holders

  • Richard Griffiths7.71%
  • FMR7.57%
  • Robert Keith6.59%
  • TCG Crossover Management, LLC4.88%
  • Artal Group S.A.4.64%
  • Tetragon Financial Management LP4.49%
  • Redmile Group, LLC3.48%
  • Citadel Advisors LLC2.21%

By investor type

  • Hedge Fund21.16%
  • Mutual Fund16.31%
  • Individual/Insider14.37%
  • VC/PE Fund12.54%
  • Public Company3.54%
  • Private Company1.32%
  • Bank/Investment Bank0.00%

Reported short interest has fallen from 4.04% to 3.89% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Tetragon Financial Management LP Hedge Fund 2026/Q3 +2,792,855 4.5%
FMR Mutual Fund 2026/Q3 +4,681,275 7.6%
Morgan Stanley Public Company 2026/Q3 +1,357,858 2.8%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +1,357,858 2.8%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +1,014,158 1.9%
Persistent Asset Partners Limited Mutual Fund 2026/Q3 +766,795 1.3%
UBS Asset Management Mutual Fund 2026/Q3 +366,526 1.0%
abrdn plc Mutual Fund 2026/Q3 +205,865 0.3%
Barclays PLC Public Company 2026/Q3 +192,540 0.3%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +135,270 0.2%
FMR Mutual Fund 2026/Q3 +586,001 1.0%
Soleus Capital Management, L.P. Hedge Fund 2026/Q3 +630,000 1.0%
Balyasny Asset Management L.P. Hedge Fund 2026/Q3 +610,980 1.0%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +370,052 0.6%
Morgan Stanley Public Company 2026/Q3 +337,686 0.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Jul 2026 Richard Griffiths Private Disposition -1,544,374 – 10,281,486
1 Jan 2026 Timothy McInerney Independent Non-Executive Director Other Derivative Acquisition +90,000 $2.05 90,000
1 Jan 2026 David Lemus Independent Non-Executive Director Other Derivative Acquisition +90,000 $2.05 90,000
1 Jan 2026 James Ede-Golightly Independent Non-Executive Director Other Derivative Acquisition +90,000 $2.05 90,000
1 Jan 2026 Steven Romano Executive VP and Chief Research & Development Officer Other Derivative Acquisition +300,000 $2.05 300,000
1 Jan 2026 Rhonda Hellums Executive VP, CFO, Secretary & Executive Director Other Derivative Acquisition +375,000 $2.05 375,000
21 Dec 2025 James Ede-Golightly Independent Non-Executive Director Other Derivative Acquisition +90,000 $2.15 90,000
17 Dec 2025 Ian Ross Other Derivative Acquisition +900,000 $2.08 900,000
13 Dec 2025 James Ede-Golightly Independent Non-Executive Director Initial Statement of Beneficial +0 – 105,333
26 Oct 2025 Richard Griffiths Other Derivative Acquisition +2,000 $7.75 11,819,861
26 Oct 2025 Richard Griffiths Open Market Derivative Acquisiti +22,000 $7.75 11,825,861
2 Aug 2025 Richard Griffiths Open Market Derivative Dispositi -20,000 $5.45 11,805,861
31 Jul 2025 Richard Griffiths Private Acquisition +18,376 – 11,220,687
29 Jul 2025 Richard Griffiths Private Acquisition +23,482 – 11,202,311
10 Jul 2025 Richard Griffiths Private Acquisition +71,293 – 11,153,484
8 Jul 2025 Richard Griffiths Private Acquisition +62,457 – 11,082,191
26 Jun 2025 Richard Griffiths Private Acquisition +110,474 – 11,019,734
23 Jun 2025 Richard Griffiths Private Acquisition +82,606 – 10,909,260
17 Jun 2025 Richard Griffiths Open Market Acquisition +70,448 $5.29 10,826,654
11 Jun 2025 Richard Griffiths Private Acquisition +39,305 – 10,756,206

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 2,418,248 3.9% 1.0
15 Oct 2026 2,927,366 4.7% 2.3
30 Sep 2026 2,538,328 4.1% 3.1
15 Sep 2026 2,178,055 3.6% 2.5
31 Aug 2026 2,435,831 4.0% 3.5
14 Aug 2026 2,432,830 4.0% 1.0

Discussion

No comments yet — be the first to weigh in on SLN.

Sign in to join the discussion.

Scroll to Top